The side effects and burden of anticoagulant treatments may contribute to poor compliance and consequently to treatment failure. The Perception of Anticoagulant Treatment Questionnaire (PACT-Q) was developed to help assess patients’ needs and their perceptions of anticoagulant treatment. The PACT-Q is a valid and reliable instrument that assesses patients’ expectations and satisfaction regarding their anticoagulant treatment, as well as their opinion about their treatments’ convenience of use. Its two-part structure – assessment of expectations at baseline in the first part, and of convenience, burden and treatment satisfaction in the second – displays good and stable psychometric properties. These results are not sufficient to recommend the use of satisfaction as a primary endpoint in clinical trials; further validation work is needed to support the interpretation of PACT-Q dimension scores. However, this first validation makes the PACT-Q an appropriate measure for use in clinical and pharmacoepidemiological research, as well as in real-life studies.
Register today to learn more about how this questionnaire can be applied in clinical research.
Mapi Research Trust is the official licensor and distributor of more than 300 COAs, on behalf of their developers and copyright owners. Please visit our catalog to access the complete list of COAs managed by Mapi Research Trust, or visit our website for additional information on our services to developers and copyright owners.
Aude Roborel de Climens, PhD, PRO Lead, Health Economics & Outcomes Research (HEOR), Sanofi
Aude Roborel de Climens, PhD, is the Clinical Outcome Assessment and Patient-Reported Outcome Lead in Diabetes and Vaccines for Sanofi, a global healthcare leader that discovers, develops and distributes therapeutic solutions for patients. In her role, she is ensuring the patient perspective is considered in drug development programs by helping clinical teams to identify what is relevant for patients and how this could be translated into endpoints which demonstrate treatment benefit for patients.Message Presenter
Paulo Carita, Modeling HEAD, Global HEVA (Health Economics & Value Assessment), Sanofi
Bio coming soon…Message Presenter
Alexia Marrel, BA, Associate Director, PRO and ClinROs - HEOR & Strategic Market Access, Patient-Centered Outcomes, Mapi, an ICON plc Company
Alexia has over 15 years’ experience in the management of international projects in the area of Patient Centred Outcomes. She has specialized interest in qualitative research, specifically in patient interviews within clinical trials, also known as mixed methods. She has delivered several client workshops on the implementation of qualitative research in clinical trials. She has participated in the development and validation of a number of PRO measures and in the design and implementation of various PRO endpoint strategies for drug clinical development programs, including several in rare diseases.Message Presenter
Marie Dulac Trimoreau, Author Relations Specialist, Author Collaboration Unit, Mapi Research Trust
Marie Dulac is an Author Relations Specialist who manages health research questionnaire distribution and licensing for Mapi Research Trust.Message Presenter
Who Should Attend?
This webinar is intended for professionals involved in:
- Clinical Research
- Academic Research
- Health Economics & Outcomes Research (HEOR)
What You Will Learn
Join this webinar to learn about the Perception of Anticoagulant Treatment Questionnaire (PACT-Q©), and how it can be used in clinical research.
- Learn the rationale and methods used in developing the PACT-Q
- Get insights on how this questionnaire can be applied in clinical research
Mapi Research Trust
Mapi Research Trust is a non-profit organization dedicated to improving patients’ quality of life by facilitating access to Patient-Centered Outcome (PCO) information. Mapi Research Trust promotes scientific approaches in the PCO field and encourages exchanges between academics, pharmaceutical companies, and international organisations around the world in the service of incorporating the patient’s voice into every step of the development process of new treatments. For nearly two decades Mapi Research Trust has been a direct contributor to nearly every translational science research program incorporating PCO. We offer free and subsidized access to thousands of independent and academic research programs in over 130 countries every year. In this manner Mapi Research Trust contributes some 4 M€ a year in services that support academic research focusing on the improvement of patients’ lives.